Skip to main content

Table 1 General characteristics of ICH patients and controls

From: Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage

Variables

ICH

Controls

P

Number of subjects

150

150

 

Age (years), (mean ± SD)

65.3 ± 11.2

64.8 ± 10.9

0.69

Sex (Male/Female)

89/61

92/58

0.72

BMI (Kg/m2)

25.7 ± 3.3

25.3 ± 3.2

0.29

Smoking status (Ever/Never)

31/119

17/133

0.03

Hypertension (Positive/Negative)

91/59

43/107

<0.001

Diabetes (Positive/Negative)

35/115

14/136

0.001

Hyperlipidemia (Positive/Negative)

43/107

22/128

0.004

TG (mg/dL)

176.3 ± 87.5

149.8 ± 75.6

0.005

TC (mg/dL)

196.8 ± 59.5

178.4 ± 51.4

0.004

HDL (mg/dL)

34.5 ± 15.6

38.9 ± 16.7

0.02

LDL (mg/dL)

127.0 ± 46.5

109.5 ± 43.7

0.001

VLDL (mg/dL)

35.3 ± 17.5

30.0 ± 15.1

0.005

ApoA1 (mg/dL)

124.1 ± 21.5

122.7 ± 21.8

0.58

ApoB (mg/dL)

89.3 ± 19.4

88.5 ± 19.2

0.72

  1. ICH intracerebral hemorrhage, BMI body mass index, TG triglyceride, TC total cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, VLDL very-low-density lipoprotein, Apo apolipoprotein